1. Abbas A.K., Lichman, A.H., Pober, J.S., 1994, Antigen processing to T lymphocytes. In Cellular and Molecular Immunology (A.K. Abbas, A.H. Lichman, and, J.S. Pober eds.), WB Saunders Co, London, pp. 16–34.
2. Bertoletti, A., Southwood, S., Chestnut, R., Sett, A., 1997, Molecular feature of hepatitis B virus nucleocapsid T cell epitope 18–27 interaction with HLA and T cell receptor. Hepatology
26:1027.
3. Gish, R.G., Keefe, E.B., 1995, Recent development in the treatment of chronic HBV infection. Exp. Opin. Invest. Drugs
4: 95–115.
4. Guidoti, L.G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., Chisari FV., 1999,Viral clearance without destruction of infected cells during acute HBV infection. Science
284: 825–829.
5. Gutfreund, K.S., Wilhams, M., Georg, R., Bain, V.G., Ma, M.M., Yoshida, E.M., et al., 2000, Genotypic succession of mutation of the hepatitis B virus polymerase associated with lamivudine resistance. J. Hepatol., 33: 469–75.